These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 172752

  • 1. Cyclic nucleotides in disease; on the biochemical etiology of hypertension.
    Amer MS.
    Life Sci; 1975 Oct 10; 17(7):1021-38. PubMed ID: 172752
    [No Abstract] [Full Text] [Related]

  • 2. Altered levels of cyclic nucleotides, cyclic AMP phosphodiesterase and adenylyl cyclase activities in normal, dysplastic and neoplastic human mammary tissue.
    Küng W, Bechtel E, Geyer E, Salokangas A, Preisz J, Huber P, Torhorst J, Jungmann RA, Talmadge K, Eppenberger U.
    FEBS Lett; 1977 Oct 01; 82(1):102-6. PubMed ID: 199454
    [No Abstract] [Full Text] [Related]

  • 3. Cyclic AMP and cyclic GMP in epidermal physiology and pathophysiology.
    Voorhees JJ, Duell EA, Creehan P, Stawiski M, Harrell ER.
    Curr Probl Dermatol; 1976 Oct 01; 6():107-53. PubMed ID: 8278
    [Abstract] [Full Text] [Related]

  • 4. Regulation of cyclic AMP and cyclic GMP in Morris hepatomas and liver.
    Hickie RA.
    Adv Exp Med Biol; 1976 Oct 01; 92():451-88. PubMed ID: 24988
    [No Abstract] [Full Text] [Related]

  • 5. Hormonal regulation of lipolysis: role of cyclic nucleotides, adenosine, and free fatty acids.
    Fain JN, Shepherd RE.
    Adv Exp Med Biol; 1979 Oct 01; 111():43-77. PubMed ID: 218431
    [No Abstract] [Full Text] [Related]

  • 6. Regulation of intracellular cyclic AMP concentrations in hepatocytes involves the integrated activation and desensitization of adenylyl cyclase coupled with the action and activation of specific isoforms of cyclic AMP phosphodiesterase.
    Houslay MD, Griffiths SL, Horton YM, Livingstone C, Lobban M, Macdonald F, Morris N, Pryde J, Scotland G, Shakur Y.
    Biochem Soc Trans; 1992 Feb 01; 20(1):140-6. PubMed ID: 1321746
    [No Abstract] [Full Text] [Related]

  • 7. The effects of nonsuppressible insulin-like protein (NSILP) on cyclic nucleotide metabolism in rat liver.
    Leichter SB, Poffenbarger PL.
    Biochem Biophys Res Commun; 1978 Sep 29; 84(2):403-10. PubMed ID: 214073
    [No Abstract] [Full Text] [Related]

  • 8. Tailoring cAMP-signalling responses through isoform multiplicity.
    Houslay MD, Milligan G.
    Trends Biochem Sci; 1997 Jun 29; 22(6):217-24. PubMed ID: 9204709
    [Abstract] [Full Text] [Related]

  • 9. Cyclic AMP metabolism in the cardiac tissue of the spontaneously hypertensive rat.
    Ramanathan S, Shibata S, Tasaki TK, Ichord RN.
    Biochem Pharmacol; 1976 Jan 15; 25(2):223-5. PubMed ID: 177025
    [No Abstract] [Full Text] [Related]

  • 10. Concerning cyclic AMP.
    Moses V.
    Sci Prog; 1976 Jan 15; 63(252):503-20. PubMed ID: 184526
    [No Abstract] [Full Text] [Related]

  • 11. Cyclic nucleotides in stroke and related cerebrovascular disorders.
    Palmer GC.
    Life Sci; 1985 May 27; 36(21):1995-2006. PubMed ID: 2860549
    [Abstract] [Full Text] [Related]

  • 12. [Fluctuations in the level of cyclic AMP and activities of adenylate cyclase and cyclic-AMP phosphodiesterase in synchronous cultures of the prokaryote Nocardia restricta (author's transl)].
    Lefebvre G, Martin N, Schneider F, Raval G, Gay R.
    Biochim Biophys Acta; 1978 May 03; 540(2):221-30. PubMed ID: 207351
    [No Abstract] [Full Text] [Related]

  • 13. cAMP and regulation of carbohydrate metabolism.
    Botsford JL.
    Basic Life Sci; 1981 May 03; 18():315-34. PubMed ID: 6268054
    [No Abstract] [Full Text] [Related]

  • 14. Changes in cyclic nucleotide metabolism in aorta and heart of neurogenically hypertensive rats: possible trigger mechanism of hypertension.
    Amer MS, Doba N, Reis DJ.
    Proc Natl Acad Sci U S A; 1975 Jun 03; 72(6):2135-9. PubMed ID: 237270
    [Abstract] [Full Text] [Related]

  • 15. Regulation of parotid gland function by cyclic nucleotides and calcium.
    Butcher FR, Putney JW.
    Adv Cyclic Nucleotide Res; 1980 Jun 03; 13():215-49. PubMed ID: 6158259
    [No Abstract] [Full Text] [Related]

  • 16. Cyclic AMP and cyclic GMP phosphodiesterase inhibition by an antiplatelet agent, 6-[(3-methylene-2-oxo-5-phenyl-5-tetrahydrofuranyl)methoxy)quinol inone (CCT-62).
    Liao CH, Tzeng CC, Teng CM.
    Eur J Pharmacol; 1998 May 15; 349(1):107-14. PubMed ID: 9669503
    [Abstract] [Full Text] [Related]

  • 17. Cyclic nucleotides in cultured cells.
    Chlapowski FJ, Kelly LA, Butcher RW.
    Adv Cyclic Nucleotide Res; 1975 May 15; 6():245-338. PubMed ID: 171929
    [No Abstract] [Full Text] [Related]

  • 18. The cyclic AMP pathway.
    Sassone-Corsi P.
    Cold Spring Harb Perspect Biol; 2012 Dec 01; 4(12):. PubMed ID: 23209152
    [Abstract] [Full Text] [Related]

  • 19. Cyclic GMP as substrate and regulator of cyclic nucleotide phosphodiesterases (PDEs).
    Juilfs DM, Soderling S, Burns F, Beavo JA.
    Rev Physiol Biochem Pharmacol; 1999 Dec 01; 135():67-104. PubMed ID: 9932481
    [No Abstract] [Full Text] [Related]

  • 20. Computer simulations of the rate of change of concentration of adenosine 3':5'-cyclic monophosphate after stimulation of adenylate cyclase activity [proceedings].
    Fell DA.
    Biochem Soc Trans; 1980 Feb 01; 8(1):139-40. PubMed ID: 6245954
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.